Publication Name	World Journal of Transplantation
Manuscript ID	21739
Country	Türkiye

Received	2015-07-30 16:20
Peer-Review Started	2015-08-06 16:54
To Make the First Decision	2015-10-08 16:54
Return for Revision	2015-10-13 16:55
Revised	2015-10-21 15:11
Second Decision	2015-11-27 16:00
Accepted by Journal Editor-in-Chief	2015-11-30 00:59
Accepted by Executive Editor-in-Chief	2015-12-08 15:22
Articles in Press	2015-12-08 15:22
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-02-20 15:44
Publish the Manuscript Online	2016-03-18 14:28

ISSN	2220-3230 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Transplantation
Manuscript Type	Minireviews
Article Title	Pentamidine in Pneumocystis jirovecii prophylaxis in heart transplant recipients
Manuscript Source	Invited Manuscript
All Author List	Adem Ilkay Diken, Ozlem Erçen Diken, Onur Hanedan, Seyhan Yılmaz, Ata Niyazi Ecevit, Emir Erol and Adnan Yalçınkaya
Funding Agency and Grant Number
Corresponding Author	Adem Ilkay Diken, MD, Assistant Professor, Department of Cardiovascular Surgery, Hitit University Faculty of Medicine, Camlik Caddesi No: 2, Bahcelievler Mahallesi, 19100 Corum, Turkey. ademilkay@gmail.com
Key Words	Pentamidine; Prophylaxis; Trimethoprim; Heart transplantation; Pneumocystis pneumonia; Pneumocystis jirovecii; Pneumocystis carinii
Core Tip	Trimethoprim/sulfomethoxazole (TMP/SMX), the first-line drug for pneumocystis pneumonia pro-phylaxis following heart transplantation, is well to-lerated, however; serious side effects have also been reported during its use. Pentamidine is an alternative prophylaxis agent when TMP/SMX cannot be tolerated following solid organ transplantations. Although there are various studies evaluating the efficiency and safety of pentamidine in these groups, merely reports were found about its usage in heart transplantation recipients. This review aims to evaluate the use of pentamidine against Pneumocystis jirovecii following heart transplantation.
Publish Date	2016-03-18 14:28
Citation	Diken AI, Diken OE, Hanedan O, Yılmaz S, Ecevit AN, Erol E, Yalçınkaya A. Pentamidine in Pneumocystis jirovecii prophylaxis in heart transplant recipients. World J Transplant 2016; 6(1): 193-198
URL	http://www.wjgnet.com/2220-3230/full/v6/i1/193.htm
DOI	http://dx.doi.org/10.5500/wjt.v6.i1.193

Full Article (PDF)	WJT-6-193.pdf
Full Article (Word)	WJT-6-193.doc
Manuscript File	21739-Review.docx
Answering Reviewers	21739-Answering reviewers.pdf
Audio Core Tip	21739-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	21739-Conflict-of-interest statement.pdf
Copyright License Agreement	21739-Copyright assignment.pdf
Peer-review Report	21739-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	21739-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	21739-Scientific misconduct check.pdf
Scientific Editor Work List	21739-Scientific editor work list.pdf